Genomic aberrations in normal appearing mucosa fields distal from oral potentially malignant lesions

[1]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[2]  Xiaoya Yang,et al.  Decoy receptor 3 expression in esophageal squamous cell carcinoma: correlation with tumour invasion and metastasis , 2011, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[3]  P. Lansdorp,et al.  RTEL1: an essential helicase for telomere maintenance and the regulation of homologous recombination , 2010, Nucleic acids research.

[4]  M. Scala,et al.  Oral Cancer Genesis and Progression: DNA Near-Diploid Aneuploidization and Endoreduplication by High Resolution Flow Cytometry , 2010, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[5]  E. Birney,et al.  A small cell lung cancer genome reports complex tobacco exposure signatures , 2009, Nature.

[6]  W. Giaretti,et al.  DNA aneuploidy and dysplasia in oral potentially malignant disorders: association with cigarette smoking and site. , 2009, Oral oncology.

[7]  R. Botella-Estrada,et al.  [Oral leukoplakia: clinical, histopathologic, and molecular features and therapeutic approach]. , 2009, Actas dermo-sifiliograficas.

[8]  R. Botella-Estrada,et al.  La leucoplasia oral: definición de parámetros clínicos, histopatológicos y moleculares y actitud terapéutica , 2009 .

[9]  Niko Beerenwinkel,et al.  Construction of oncogenetic tree models reveals multiple pathways of oral cancer progression , 2009, International journal of cancer.

[10]  Stephen C. West,et al.  RTEL1 Maintains Genomic Stability by Suppressing Homologous Recombination , 2008, Cell.

[11]  C. R. Leemans,et al.  Comparative evaluation of genetic assays to identify oral pre-cancerous fields. , 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[12]  C. Scully,et al.  Oral potentially malignant lesions: first-level micro-histological diagnosis from tissue fragments sampled in liquid-based diagnostic cytology. , 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[13]  G. de Rosa,et al.  Prognostic value of human telomerase reverse transcriptase gene expression in oral carcinogenesis. , 2007, International journal of oncology.

[14]  G. Dakubo,et al.  Clinical implications and utility of field cancerization , 2007, Cancer Cell International.

[15]  T. Axéll,et al.  Management of oral epithelial dysplasia: a review. , 2007, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[16]  G. Lodi,et al.  Interventions for treating oral leukoplakia. , 2006, The Cochrane database of systematic reviews.

[17]  Shu-Chun Lin,et al.  Array‐comparative genomic hybridization to detect genomewide changes in microdissected primary and metastatic oral squamous cell carcinomas , 2006, Molecular carcinogenesis.

[18]  T. Furuya,et al.  Comparative genomic hybridization reveals genetic progression of oral squamous cell carcinoma from dysplasia via two different tumourigenic pathways , 2006, The Journal of pathology.

[19]  P J F Snijders,et al.  Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus , 2006, Oncogene.

[20]  D. Trisciuoglio,et al.  Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function , 2005, Cell Death and Differentiation.

[21]  Han-Woong Lee,et al.  The pleiotropy of telomerase against cell death. , 2005, Molecules and cells.

[22]  J. Fridlyand,et al.  Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma , 2005, Oncogene.

[23]  C. R. Leemans,et al.  A genetic progression model of oral cancer: current evidence and clinical implications. , 2004, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[24]  D. Albertson,et al.  Chromosome aberrations in solid tumors , 2003, Nature Genetics.

[25]  C. R. Leemans,et al.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. , 2003, Cancer research.

[26]  S. Kamel‐Reid,et al.  Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysis , 2002, Head & neck.

[27]  C. R. Leemans,et al.  Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. , 2002, Head & neck.

[28]  G. Snow,et al.  Second primary tumors and field cancerization in oral and oropharyngeal cancer: Molecular techniques provide new insights and definitions , 2002 .

[29]  C. R. Leemans,et al.  Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  S. Gollin.  Chromosomal alterations in squamous cell carcinomas of the head and neck: Window to the biology of disease , 2001, Head & neck.

[31]  R. Brakenhoff,et al.  Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  T. Liehr,et al.  Oral squamous cell carcinomas are characterized by a rather uniform pattern of genomic imbalances detected by comparative genomic hybridisation. , 1998, Oral oncology.

[33]  A. Huvos,et al.  Molecular support for field cancerization in the head and neck , 1998, Cancer.

[34]  W. Giaretti,et al.  Consensus Report of the Task Force on Standardisation of DNA Flow Cytometry in Clinical Pathology , 1998, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[35]  G. Snow,et al.  Biologic implications of genetic changes in head and neck squamous cell carcinogenesis. , 1997, The Australian and New Zealand journal of surgery.

[36]  S. Piantadosi,et al.  Poster 7: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996, Cancer research.

[37]  J. Califano,et al.  11:40 AM: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996 .

[38]  W. Giaretti.  A model of DNA aneuploidization and evolution in colorectal cancer. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[39]  F. Bosch,et al.  Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. , 1993, Cancer research.

[40]  W. Hong,et al.  Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis. , 1993, Cancer research.

[41]  D. Slaughter,et al.  “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin , 1953, Cancer.

[42]  K Davidson,et al.  TOBACCO-SMOKING , 1889, Science.

[43]  I. Tohnai,et al.  Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma. , 2009, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[44]  I. van der Waal,et al.  Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. , 2009, Oral oncology.

[45]  G. Collins.  The next generation. , 2006, Scientific American.

[46]  L. Barnes,et al.  Pathology and genetics of head and neck tumours , 2005 .

[47]  M. Thun,et al.  Tobacco smoke and involuntary smoking. , 2004, IARC monographs on the evaluation of carcinogenic risks to humans.

[48]  F J Otto,et al.  High-resolution analysis of nuclear DNA employing the fluorochrome DAPI. , 1994, Methods in cell biology.

[49]  S. Taylor.  Head and neck cancer. , 1991, Cancer chemotherapy and biological response modifiers.

[50]  Robert C. Wolpert,et al.  A Review of the , 1985 .